COO

The Cooper Companies, Inc (COO)

$82.08

Last Close (24-hour delay)

Profit since last BUY7.99%

Consider higher Upturn Star rating

BUY since 14 days

• BUY Advisory
• SELL Advisory (Profit)
• SELL Advisory (Loss)

• Profit
• Loss
• Pass (Skip investing)

Stock price based on last close

*as per simulation
(see disclosures)

Upturn Star Rating

Below Average Performance

These Stocks/ETFs, based on Upturn Advisory, often underperform the market, warranting careful consideration before investing.

Number of Analysts

19 Analysts rated it

Moderately tracked stock, growing coverage, gaining market and investor attention.

Analysis of Past Performance

Type Stock

Historic Profit 21.3%

Avg. Invested days 39

Today’s Advisory Consider higher Upturn Star rating

Upturn Star Rating

Upturn Advisory Performance 4.0

Stock Returns Performance 3.0

Profits based on simulation

Last Close 12/12/2025

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia. Its CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage. This segment offers Paragard, a hormone-free intrauterine device; and fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.